ArticleFrontiers in immunology2026
Single-cell and spatial multi-omics reveal estrogen-mediated vaginal wall microenvironment remodeling and a perivascular reparative niche in postmenopausal pelvic organ prolapse.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Local estrogen is widely used to improve vaginal mucosal status and relieve menopausal urogenital symptoms in patients with pelvic organ prolapse (POP), yet clinical outcomes are inconsistent. This creates an urgent need to clarify the tissue-specific mechanisms of estrogen action. Methods: In this study, we combined single-cell RNA sequencing and high-resolution Visium HD spatial transcriptomics to profile postmenopausal vaginal wall tissues at near-cellular resolution. Computational pharmacology analysis was also performed to predict distinct responses of this tissue niche to different estrogen subtypes. Results: We found estrogen drives selective expansion and spatial redistribution of HAS1+ fibroblasts, which aggregate with pericytes to form a structured perivascular niche. Such spatial co-localization strengthens fibroblast-pericyte crosstalk and activates multiple pro-repair signaling cascades. Discussion: Our results demonstrate that estrogen functions by forming spatially organized multicellular reparative niches rather than non-selective tissue activation. This work provides a theoretical basis for developing targeted POP therapies, while further experimental verification is still needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.